According to Zealand Pharma's latest financial reports and stock price the company's current Operating Margin is -961.39%. At the end of 2022 the company had an Operating Margin of -880.49%.
Year | Operating Margin | Change |
---|---|---|
2022 | -880.49% | 151.85% |
2021 | -349.61% | 47.62% |
2020 | -236.83% | -82.93% |
2019 | -1,387.44% | -182.31% |
2018 | 1,685.59% | -1010.16% |
2017 | -185.20% | 241.68% |
2016 | -54.20% | 16.75% |
2015 | -46.42% | 1.3% |
2014 | -45.83% | -98.36% |
2013 | -2,792.74% | -17178.61% |
2012 | 16.35% | 51.79% |
2011 | 10.77% | -109% |
2010 | -119.71% | -59.91% |
2009 | -298.61% | 275.94% |
2008 | -79.43% | -23.88% |
2007 | -104.35% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.